by Cort Johnson | Oct 10, 2020 | COVID-19, Homepage, POTS
The Paradox An earlier blog focused on the “renin-aldosterone paradox” in chronic fatigue syndrome (ME/CFS) and postural orthostatic tachycardia syndrome (POTS). The renin-angiotensin-aldosterone system (RAAS) regulates blood volume and a whole bunch of...
by Cort Johnson | Aug 15, 2020 | COVID-19, Cytokines, Homepage, long COVID
Could COVID-19 studies already be providing clues about what went wrong with the long haulers and people with post-infectious chronic fatigue syndrome (ME/CFS), fibromyalgia and other diseases? Two articles in the New York Times – a feature length one,...
by Cort Johnson | Aug 12, 2020 | Epstein-Barr Virus, Homepage, Pathogens
An old drug called spironolactone opens the door to a new generation of more effective Epstein-Barr virus drugs that could help with chronic fatigue syndrome, long COVID and other diseases.
by Cort Johnson | Aug 5, 2020 | COVID-19, Homepage, long COVID
A couple of weeks ago Health Rising posted a kind of wakeup call for the COVID-19 long haulers. Borne out of decades of experience with ME/CFS, it was admittedly a pretty harsh piece – not easy to take in. An Open Letter to the COVID-19 Long Hauler Community...
by Cort Johnson | Jul 24, 2020 | COVID-19, Homepage
“If you look anecdotally, there is no question that there are a considerable number of individuals who have a post-viral syndrome that in many respects incapacitates them for weeks and weeks following so-called recovery. They report symptoms such as brain fog,...
by Cort Johnson | Jul 22, 2020 | Epstein-Barr Virus, Pathogens
In a surprise a 50 year old drug called Spironolactone points the way to a new generation of Epstein-Barr virus and probaby herpesvirus drugs as well.